Immunitybio Inc logo

IBRX

NASDAQ

Immunitybio Inc

$7.30+0.41 (+5.95%)
Key Statistics
Market Cap$7.54B
P/E RatioN/A
Div. Yield
EPS (TTM)-$0.38
52W High$12.43
52W Low$1.83
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees691
Price Performance
1 Week-1.08%
3 Month+250.96%
1 Year+145.79%
FinancialsAnnual · QuiverQuant
Revenue$622,000
Assets$504.45M
Liabilities$1.09B
Net Income$583.85M loss

About

ImmunityBio, Inc., an immunotherapy company, develops a memory T-cell cancer vaccine to fight multiple types of tumors without the use of high-dose chemotherapy.

WebullFree stocks

Advanced charting, extended hours trading, and free stock for new accounts.

Open Account
Analyze IBRX with professional charts— Free to start

Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.